Zeo Scientifix, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
OQB
George Shapiro, M.D. has filed an amended Schedule 13G, reporting beneficial ownership of 1,311,271 shares, representing 15.1% of Zeo Scientifix, Inc.'s common stock.